Genenta Science S P A (GNTA) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Genenta Science S p a   (NASDAQ: GNTA)


Genenta Science S P A's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Genenta Science S P A's ROI in the fourth quarter of 2025?
Genenta Science S P A recorded a cumulative net loss of $-7 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -26.73%.

Within the Healthcare sector 373 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 3826.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 95.68 % 33.75 % 3.92 % -19.69 % -38.84 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 35 25 25 25 13
Return On Investment (TTM) -26.73 % -45.55 % -51.8 % -60.04 % -71.4 %
GNTA's Overall Ranking # 3826 # # # # 4752
Seq. Investment Change TTM 24.84 % 13.72 % 15.91 % 18.92 % -14.67 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -7 -10 -10 -10 -10

GNTA Company Profile >> Back to GNTA Roi Comparisons >> See Annual GNTA Return On Investment



Return On Investment GNTA's Ranking
Within: No.
Industry # 44
Sector # 374
Overall # 3826

Return On Investment Statistics
High Average Low
-16.99 %
-42.93 %
-73.22 %
(Dec 31 2025)   (Dec 31 2024)







Financial Statements
Genenta Science S P A's IV. Quarter Investments $ 35 Millions GNTA's Balance sheet
Genenta Science S P A's IV. Quarter Income $ -7 Millions Quarterly GNTA's Income Statement
GNTA's Income by Division See GNTA's Income by Division


GNTA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 35 13 23 33 44
Y / Y Investment Growth 165.3 % -42.2 % -31.8 % -24.11 % -
Net Income in Millions -7 -10 -13 -9 -7
Y / Y Net Income Growth - - - - -
Annual Return On Investment -21.13 % -73.22 % -55.29 % -26.73 % -14.86 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GNTA's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GNTA's Competitors
Subscribers only: Roi for Genenta Science S P A's Suppliers
Subscribers only: Return On Investment for GNTA's Customers

Other Ratios
GNTA's Roa GNTA's Inventory Turnover Ratio GNTA's Growth Rates GNTA's Dividend Statistics
GNTA's Profitability Ratios GNTA's Asset Turnover Ratio GNTA's Dividend Growth
GNTA's Roe GNTA's Valuation Ratios GNTA's Financial Strength Ratios GNTA's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-07-07T11:25:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.